170 related articles for article (PubMed ID: 37189167)
1. Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity.
Cascianelli S; Barbera C; Ulla AA; Grassi E; Lupo B; Pasini D; Bertotti A; Trusolino L; Medico E; Isella C; Masseroli M
Genome Med; 2023 May; 15(1):37. PubMed ID: 37189167
[TBL] [Abstract][Full Text] [Related]
2. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer.
Isella C; Brundu F; Bellomo SE; Galimi F; Zanella E; Porporato R; Petti C; Fiori A; Orzan F; Senetta R; Boccaccio C; Ficarra E; Marchionni L; Trusolino L; Medico E; Bertotti A
Nat Commun; 2017 May; 8():15107. PubMed ID: 28561063
[TBL] [Abstract][Full Text] [Related]
3. Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
Alderdice M; Richman SD; Gollins S; Stewart JP; Hurt C; Adams R; McCorry AM; Roddy AC; Vimalachandran D; Isella C; Medico E; Maughan T; McArt DG; Lawler M; Dunne PD
J Pathol; 2018 May; 245(1):19-28. PubMed ID: 29412457
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
[TBL] [Abstract][Full Text] [Related]
5. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients.
van de Weerd S; Smit MA; Roelands J; Mesker WE; Bedognetti D; Kuppen PJK; Putter H; Tollenaar RAEM; Roodhart JML; Hendrickx W; Medema JP; van Krieken JHJM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293565
[TBL] [Abstract][Full Text] [Related]
7. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
Eilertsen IA; Moosavi SH; Strømme JM; Nesbakken A; Johannessen B; Lothe RA; Sveen A
Cancer Lett; 2020 Jan; 469():246-255. PubMed ID: 31678167
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathological classification of colorectal cancer-an update.
Dunne PD; Arends MJ
Virchows Arch; 2024 Feb; 484(2):273-285. PubMed ID: 38319359
[TBL] [Abstract][Full Text] [Related]
9. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapy.
Allen WL; Dunne PD; McDade S; Scanlon E; Loughrey M; Coleman H; McCann C; McLaughlin K; Nemeth Z; Syed N; Jithesh P; Arthur K; Wilson R; Coyle V; McArt D; Murray GI; Samuel L; Nuciforo P; Jimenez J; Argiles G; Dienstmann R; Tabernero J; Messerini L; Nobili S; Mini E; Sheahan K; Ryan E; Johnston PG; Van Schaeybroeck S; Lawler M; Longley DB
JCO Precis Oncol; 2018 Jun; 2018():. PubMed ID: 30088816
[TBL] [Abstract][Full Text] [Related]
12. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
Sirinukunwattana K; Domingo E; Richman SD; Redmond KL; Blake A; Verrill C; Leedham SJ; Chatzipli A; Hardy C; Whalley CM; Wu CH; Beggs AD; McDermott U; Dunne PD; Meade A; Walker SM; Murray GI; Samuel L; Seymour M; Tomlinson I; Quirke P; Maughan T; Rittscher J; Koelzer VH;
Gut; 2021 Mar; 70(3):544-554. PubMed ID: 32690604
[TBL] [Abstract][Full Text] [Related]
13. Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.
Linnekamp JF; Hooff SRV; Prasetyanti PR; Kandimalla R; Buikhuisen JY; Fessler E; Ramesh P; Lee KAST; Bochove GGW; de Jong JH; Cameron K; Leersum RV; Rodermond HM; Franitza M; Nürnberg P; Mangiapane LR; Wang X; Clevers H; Vermeulen L; Stassi G; Medema JP
Cell Death Differ; 2018 Mar; 25(3):616-633. PubMed ID: 29305587
[TBL] [Abstract][Full Text] [Related]
14. Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal Cancer.
Bramsen JB; Rasmussen MH; Ongen H; Mattesen TB; Ørntoft MW; Árnadóttir SS; Sandoval J; Laguna T; Vang S; Øster B; Lamy P; Madsen MR; Laurberg S; Esteller M; Dermitzakis ET; Ørntoft TF; Andersen CL
Cell Rep; 2017 May; 19(6):1268-1280. PubMed ID: 28494874
[TBL] [Abstract][Full Text] [Related]
15. Development of a miRNA-based classifier for detection of colorectal cancer molecular subtypes.
Adam RS; Poel D; Ferreira Moreno L; Spronck JMA; de Back TR; Torang A; Gomez Barila PM; Ten Hoorn S; Markowetz F; Wang X; Verheul HMW; Buffart TE; Vermeulen L
Mol Oncol; 2022 Jul; 16(14):2693-2709. PubMed ID: 35298091
[TBL] [Abstract][Full Text] [Related]
16. Patients with mesenchymal tumours and high
Salvucci M; Crawford N; Stott K; Bullman S; Longley DB; Prehn JHM
Gut; 2022 Aug; 71(8):1600-1612. PubMed ID: 34497144
[TBL] [Abstract][Full Text] [Related]
17. Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content.
Miller SA; Ghobashi AH; O'Hagan HM
Cancer Genet; 2021 Jun; 254-255():34-39. PubMed ID: 33571895
[TBL] [Abstract][Full Text] [Related]
18. Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification.
Dunne PD; Alderdice M; O'Reilly PG; Roddy AC; McCorry AMB; Richman S; Maughan T; McDade SS; Johnston PG; Longley DB; Kay E; McArt DG; Lawler M
Nat Commun; 2017 May; 8():15657. PubMed ID: 28561046
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
20. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines.
Schlicker A; Beran G; Chresta CM; McWalter G; Pritchard A; Weston S; Runswick S; Davenport S; Heathcote K; Castro DA; Orphanides G; French T; Wessels LF
BMC Med Genomics; 2012 Dec; 5():66. PubMed ID: 23272949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]